Hanson & Doremus Investment Management Amarin Corp Plcuk Transaction History

Hanson & Doremus Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$2.85 - $3.73 $6,626 - $8,672	-2,325 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$4.78 - $8.26 $3,824 - $6,608	800 Added 52.46%	2,325 $16,000
Q1 2020 Apr 24, 2020	BUY	$4.0 - $21.53 $2,000 - $10,765	500 Added 48.78%	1,525 $6,000
Q4 2018 Jan 31, 2019	BUY	$12.41 - $22.98 $6,018 - $11,145	485 Added 89.81%	1,025 $14,000
Q3 2017 Oct 26, 2017	BUY	$3.03 - $3.72 $1,636 - $2,008	540	540 $0

183

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $190M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

Stay updated on Hanson & Doremus Investment Management with notifications on news.